When Big Pharma puts out a $14 million dollar Super Bowl commercial, is that dipping into the research budget? Or is that part of a larger operating cost endured by these companies–the costs of making their brand a household name, of paying doctors to make subscriptions, and of lobbying for a congenial political climate?
Group items tagged
Pharmaceuticals, Patents, and the Media « Digifesto - 1 views
-
-
how does one design a news dissemination network with mass appeal that both provides attractive content while minimizing potential for abuse by economic interests that are adversarial to the network users?
Is Pinterest the Risk-Free Social Channel for Pharma? - 0 views
-
"I recently came across a blog post headlining Pinterest as the "safest place" for medical marketers to start with social media. All too aware that there are many Pharma marketers out there still a little shy of social, it was a must read. Launched just three years ago, Pinterest has enjoyed phenomenal expansion of its user base, posting growth of 1,000 percent in 2012. As of June 2013 it had more than 48 million users, generating 2.5 billion page views a month. With a demographic skewed heavily towards 25 to 34 year-old women, half of them with children, the potential for marketers seems real. If you're not sure exactly what Pinterest is, imagine a huge virtual pinboard where users display pictures they like. Users can pin up their own images, but mostly they pin images from other people's websites or re-pin images previously posted on Pinterest - 80 percent of the images on Pinterest have been re-pinned, or shared, within the network. It's this re-pinning that makes Pinterest interesting for brands - the opportunity to harness the viral power of social sharing is enormous. In a recent adoption rates study, social media analytics firm Simply Measured reported that 69 percent of the Interbrand top 100 brands are on Pinterest."
PharmTech Talk » Social Media and the Pharma Industry - 0 views
-
For the pharmaceutical industry, social media poses concerns that range from release of propriety information to regulatory constraints to patient safety. These concerns have limited the industry’s use of a potential marketing and networking tool. Other industries are using Twitter, Facebook, and other social media outlets to promote products, follow consumer trends, and connect directly with their consumers. Is social media being used effectively at all in the pharmaceutical industry? Are there ways social media can be positively used by industry members to share ideas, connect with industry members, or even promote products? And if there is a fear of regulatory infractions, what can or should FDA and other international regulatory agencies do to promote the use of social media?
E-réputation : le bon laboratoire, la brute Google et… le réseau social | le ... - 0 views
-
les réseaux sociaux spécifiques à la santé : Carenity, Docatus, Sermo, Mypsink
1 - 5 of 5
Showing 20▼ items per page